Venous Ethanol for Ventricular Tachycardia
A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 156 participants.
Also called NCT05511246
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 156 participants
- Registry
-
NCT05511246
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT05511246. Randomized; triple masking; primary purpose treatment. Start 2023-04-12 (actual); primary completion 2027-12-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Venous Ethanol for Ventricular Tachycardia
- Acronym
- VELVET
- Condition
- Ventricular Tachycardia
- Condition
- Ischemic Cardiomyopathy
- Intervention (Drug)
- Venous ethanol
- Intervention (Procedure)
- Catheter ablation
- Lead sponsor
- The Methodist Hospital Research Institute
Record details
- Record id
cardio:ct-nct05511246- Content hash
68eb431680e744f1696c07b33d12a87e72dc2d2281334acdb416b9a835336486